D. Petruzzellis

An IL28B Polymorphism Determines Treatment Response of Hepatitis C Virus Genotype 2 or 3 Patients Who Do Not Achieve a Rapid Virologic Response

Alessandra Mangia, Alexander Thompson, Rosanna Santoro et al. · Gastroenterology · 2010 · 316 citations · Full text

Life Sciences, Genetics, Immunology +13

Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR

Alexander Thompson, Rosanna Santoro, Valeria Piazzolla et al. · Hepatology · 2010 · 73 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection #

Alessandra Mangia, Nicola Minerva, Donato Bacca et al. · Hepatology · 2008 · 66 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring

Alessandra Mangia, Alexander Thompson, Rosanna Santoro et al. · Hepatology · 2011 · 57 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Il28B Cc-Genotype Association with Hla-Dqb1*0301 Allele Increases the Prediction of Spontaneous HCV RNA Clearance in Thalassaemic HCV-Infected Patients

Alessandra Mangia, Rosanna Santoro, Roberto Sarli et al. · Antiviral Therapy · 2011 · 19 citations · Full text

Life Sciences, Genetics, Immunology +17